DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons
Business Model:
Revenue: $16.8M
Employees: 11-50
Address: 14612 Big Basin Way
City: Saratoga
State: CA
Zip: 95070
Country: US
DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons learned from a history of successful investing and building successful companies. They believed that their unique combination of skills and perspectives could help entrepreneurs to build companies which would have significant clinical impact and generate superior returns. Seven years later, this belief continues to hold true, demonstrated by investment success in selected medical device and biotechnology companies. With $650 million under management, De Novo has made more than 40 investments in medical devices and biotechnology across three funds. They invest in all stages of enterprise development and growth – from early stage to late stage. The unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company.
Contact Phone:
+16503291999
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2012 | Benvenue Medical | Series D | 25M |
6/2014 | Benvenue Medical | Series E | 40M |
3/2004 | Spinal Kinetics | Series A | 10M |
4/2003 | iScience Interventional | Series C | 15M |
7/2007 | CardioMind | Series C | 11M |
3/2008 | CardioMind | Venture Round | 22M |
12/2009 | EBR Systems | Venture Round | 15M |
3/2006 | Cartilix | Series B | 6.3M |
10/2005 | EBR Systems | Series B | 21M |
2/2009 | SynergEyes | Series C | 0 |
10/2008 | InSound Medical | Series E | 13M |
8/2007 | Sierra Surgical | Series A | 7.1M |
10/2007 | Vitreoretinal Technologies | Series A | 12M |
4/2010 | Articulinx Inc. | Series B | 10M |
7/2008 | Sierra Surgical | Series B | 14.5M |
11/2007 | Viracta Therapeutics | Series A | 20M |
4/2010 | Viracta Therapeutics | Series B | 12M |
11/2005 | FlowMedica | Series D | 0 |
3/2004 | InSound Medical | Series D | 17.2M |
3/2011 | Astute Medical | Series B | 13M |
11/2005 | Ovalis | Series A | 0 |
5/2007 | Pulmonx | Series B | 20M |
8/2001 | MicroVention Terumo | Series C | 12.5M |
3/2012 | Viracta Therapeutics | Series B | 0 |
5/2010 | Astute Medical | Series B | 26.5M |
9/2011 | Simpirica Spine | Series C | 22M |
10/2005 | PhotoThera | Series B | 19M |
2/2011 | EBR Systems | Series D | 5M |
7/2008 | MyoScience | Series B | 0 |
3/2003 | iScience Surgical | Series B | 0 |
6/2004 | EBR Systems | Series A | 5.2M |
9/2013 | MyoScience | Series E | 0 |
3/2012 | MyoScience | Series D | 0 |
6/2004 | Paracor Medical | Series C | 30.5M |
6/2007 | Paracor Medical | Series D | 44M |
6/2009 | Facet Solutions | Debt Financing | 4.1M |
8/2007 | EndoGastric Solutions | Series D | 30M |
5/2009 | PhotoThera | Series D | 50M |
6/2011 | Spinal Modulation | Series D | 0 |
1/2016 | Benvenue Medical | Equity | 23M |
7/2003 | Bacchus Vascular | Series D | 25M |
4/2006 | SynergEyes | Series B | 0 |
5/2014 | EndoGastric Solutions | Series G | 0 |
4/2017 | Avedro | Venture Round | 0 |
4/2006 | PhotoThera | Series C | 30.5M |
5/2009 | iScience Interventional | Series F | 20.5M |
5/2007 | Talima Therapeutics | Series B | 19M |
11/2008 | OncoMed Pharmaceuticals | Series B | 154M |
6/2008 | EBR Systems | Series C | 35M |
5/2007 | TRIA Beauty | Series D | 0 |
1/2008 | Avedro | Series A | 8M |
1/2006 | Spinal Kinetics | Series B | 36M |
1/2002 | Renovis | Series B | 0 |
3/2005 | iScience Surgical | Series C | 0 |
12/2005 | Facet Solutions | Series B | 16.5M |
5/2005 | Bayhill Therapeutics | Series B | 35.4M |
9/2009 | Spinal Kinetics | Debt Financing | 5.3M |
1/2008 | POINT Biomedical | Private Equity Round | 0 |
1/2012 | iScience Interventional | Venture Round | 2.8M |
5/2010 | TearScience | Series C | 44.5M |
2/2011 | Spiracur | Series C | 35M |
4/2012 | WaveTec Vision | Venture Round | 0 |
1/2003 | Lumend | Series D | 23.2M |
7/2013 | TRIA Beauty | Private Equity Round | 0 |
4/2016 | TearScience | Series D | 0 |
2/2011 | TRIA Beauty | Venture Round | 26.3M |
10/2012 | TRIA Beauty | Venture Round | 7.5M |
2/2009 | WaveTec Vision | Series C | 20.1M |
8/2010 | EndoGastric Solutions | Series F | 0 |
6/2009 | EndoGastric Solutions | Venture Round | 3.8M |
6/2012 | Astute Medical | Series C | 40.4M |
5/2011 | WaveTec Vision | Series D | 15.9M |
5/2007 | WaveTec Vision | Series B | 13M |
4/2011 | Benvenue Medical | Series C | 35.5M |
1/2006 | Spinal Modulation | Series A | 7M |
4/2006 | Bayhill Therapeutics | Venture Round | 15.8M |
6/2014 | Spinal Kinetics | Venture Round | 34M |
6/2009 | Spiracur | Series B | 20.3M |
1/2012 | Pulmonx | Private Equity Round | 0 |
3/2010 | Pulmonx | Series C | 0 |
1/2007 | TearScience | Series B | 15.1M |
1/2007 | Ovalis | Series B | 0 |
5/2018 | Avedro | Series F | 0 |
1/2023 | Milo | Series A | 0 |
4/2012 | EndoGastric Solutions | Venture Round | 0 |
5/2005 | Talima Therapeutics | Series A | 1.6M |
11/2009 | EndoGastric Solutions | Series E | 0 |
10/2009 | EndoGastric Solutions | Venture Round | 0 |
6/2012 | EndoGastric Solutions | Venture Round | 0 |
3/2013 | Avedro | Series D | 0 |
5/2008 | Astute Medical | Series A | 6.3M |
7/2006 | InSound Medical | Series E | 18.9M |
1/2008 | Benvenue Medical | Series B | 15M |
11/2009 | Spinal Modulation | Series C | 27.4M |
2/2008 | InSound Medical | Series E | 11M |
12/2007 | AxoGen | Post-IPO Equity | 12.1M |
5/2018 | Avedro | Series F | 0 |
4/2017 | Avedro | Venture Round | 0 |
4/2016 | TearScience | Series D | 0 |
1/2016 | Benvenue Medical | Series F | 0 |
6/2014 | Benvenue Medical | Series E | 0 |
6/2014 | Spinal Kinetics | Venture Round | 0 |
5/2014 | EndoGastric Solutions | Series G | 0 |
9/2013 | MyoScience | Series E | 0 |
7/2013 | TRIA Beauty | Private Equity Round | 0 |
3/2013 | Avedro | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|